Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02137759
Title MRSI to Predict Response to RT/TMZ and Vorinostat in GBM
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

gliosarcoma

glioblastoma

Therapies

Vorinostat

Temozolomide

Age Groups: adult
Covered Countries USA


No variant requirements are available.